Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data (Q31122446)

29 June 2017

title

Recent cancer survival in Europe: a 2000-02 period analysis of EUROCARE-4 data (English)

1 reference

29 June 2017

3

1 reference

29 June 2017

2

0 references

Andrea Micheli

object named as

Andrea Micheli

5

0 references

Gemma Gatta

object named as

Gemma Gatta

4

0 references

author name string

Arduino Verdecchia

1

1 reference

29 June 2017

Lucia Mangone

6

1 reference

29 June 2017

Ian Kunkler

7

1 reference

29 June 2017

EUROCARE-4 Working Group

8

1 reference

29 June 2017

publication date

1 September 2007

1 reference

Lancet Oncology Commission

29 June 2017

published in

1 reference

29 June 2017

volume

8

1 reference

29 June 2017

issue

9

1 reference

29 June 2017

page(s)

784-796

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970246-2

29 June 2017

1 reference

7 January 2021

Childhood cancer survival in Europe, 1978-1992: the EUROCARE study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970246-2

7 January 2021

EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970246-2

7 January 2021

The Calman-Hine report: a personal retrospective on the UK's first comprehensive policy on cancer services

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970246-2

7 January 2021

Long-term survival rates of cancer patients achieved by the end of the 20th century: a period analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970246-2

7 January 2021

Permutation tests for joinpoint regression with applications to cancer rates

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970246-2

7 January 2021

Use of period analysis for providing more up-to-date estimates of long-term survival rates: empirical evaluation among 370 000 cancer patients in Finland

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970246-2

7 January 2021

Up-to-Date Long-Term Survival Curves of Patients With Cancer by Period Analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970246-2

7 January 2021

Up-to-date long-term survival of cancer patients: an evaluation of period analysis on Swedish Cancer Registry data

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970246-2

7 January 2021

An empirical evaluation of period survival analysis using data from the Canadian Cancer Registry

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970246-2

7 January 2021

The relative survival rate

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970246-2

7 January 2021

A computer program package for relative survival analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970246-2

7 January 2021

Cancer survival corrected for heterogeneity in patient withdrawal.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970246-2

7 January 2021

Standard cancer patient population for age standardising survival ratios

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970246-2

7 January 2021

Electronic availability of EUROCARE-3 data: a tool for further analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970246-2

7 January 2021

Interpreting international comparisons of cancer survival: the effects of incomplete registration and the presence of death certificate only cases on survival estimates.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970246-2

7 January 2021

The impact of the Calman-Hine report: analysis of breast and colorectal cancer surgical workloads and the degree of surgical site specialization in the Yorkshire region of the UK, 1990-2000.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970246-2

7 January 2021

Impact of a surgical training programme on rectal cancer outcomes in Stockholm.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970246-2

7 January 2021

International trends in prostate-cancer mortality: the decrease is continuing and spreading.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970246-2

7 January 2021

Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970246-2

7 January 2021

Breast cancer screening practices among women in the United States, 2000.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970246-2

7 January 2021

Prostate cancer screening between low-income African-American and Caucasian men.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970246-2

7 January 2021

Effect of screening and adjuvant therapy on mortality from breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970246-2

7 January 2021

Effect of NHS breast screening programme on mortality from breast cancer in England and Wales, 1990-8: comparison of observed with predicted mortality

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970246-2

7 January 2021

Cancer survival increases in Europe, but international differences remain wide.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970246-2

7 January 2021

Towards evidence-based guidelines for radiotherapy infrastructure and staffing needs in Europe: the ESTRO QUARTS project.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2807%2970246-2

7 January 2021

10.1016/S1470-2045(07)70246-2

Identifiers

DOI

1 reference

29 June 2017

1 reference